サマリー

咽頭癌治療薬の世界市場 2022-2026 年
Technavioは咽頭癌治療薬市場を監視しており、2022-2026年の間に18億2000万ドルの成長が見込まれ、予測期間中にCAGR6.7％で加速しています。当レポートでは、咽頭癌治療薬市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、咽頭癌の発生率の増加、タバコ製品の使用量の増加、リスク要因の増加によって牽引されています。
咽頭癌治療薬市場の分析には、タイプ別セグメントと地域別の展望が含まれます。
Technavioの咽頭癌治療薬市場は、以下のように区分されています。
タイプ別
- 咽頭癌
- 喉頭癌
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、戦略的提携が今後数年間における咽頭癌治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、患者支援プログラムや強力なパイプラインは、市場の大きな需要につながるでしょう。
Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。咽頭癌治療薬市場に関する当レポートは、以下の分野を対象としています。
- 咽頭癌治療薬市場のサイジング
- 咽頭癌治療薬市場の予測
- 咽頭癌治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Amgen Inc.、AstraZeneca Plc、Bayer AG、Bristol Myers Squibb Co、Celldex Therapeutics Inc、Eli Lilly and Co、F. Hoffmann La Roche Ltd., Hangzhou Adlai Nortye Biopharma Co.Ltd.、Merck KGaA、Pfizer Inc、Regeneron Pharmaceuticals Inc、Sanofi、Spectrum Pharmaceuticals Inc、Accord Healthcare Ltd.、Athenex Inc、Fresenius SE, and Co.KGaA、Hikma Pharmaceuticals Plc、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、WG Critical Care LLCの6社です。また、咽頭癌治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/throat-cancer-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Pharyngeal cancer - Market size and forecast 2021-2026
o Exhibit 28: Chart on Pharyngeal cancer - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Pharyngeal cancer - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Pharyngeal cancer - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Pharyngeal cancer - Year-over-year growth 2021-2026 (%)
o 5.4 Laryngeal cancer - Market size and forecast 2021-2026
o Exhibit 32: Chart on Laryngeal cancer - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Laryngeal cancer - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Laryngeal cancer - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Laryngeal cancer - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Hungary - Market size and forecast 2021-2026
o Exhibit 62: Chart on Hungary - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Hungary - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Hungary - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Hungary - Year-over-year growth 2021-2026 (%)
o 7.9 India - Market size and forecast 2021-2026
o Exhibit 66: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.10 Poland - Market size and forecast 2021-2026
o Exhibit 70: Chart on Poland - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Poland - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Poland - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Poland - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Amgen Inc.
o Exhibit 85: Amgen Inc. - Overview
o Exhibit 86: Amgen Inc. - Product / Service
o Exhibit 87: Amgen Inc. - Key offerings
o 10.4 AstraZeneca Plc
o Exhibit 88: AstraZeneca Plc - Overview
o Exhibit 89: AstraZeneca Plc - Product / Service
o Exhibit 90: AstraZeneca Plc - Key news
o Exhibit 91: AstraZeneca Plc - Key offerings
o 10.5 Bristol Myers Squibb Co.
o Exhibit 92: Bristol Myers Squibb Co. - Overview
o Exhibit 93: Bristol Myers Squibb Co. - Product / Service
o Exhibit 94: Bristol Myers Squibb Co. - Key offerings
o 10.6 Celldex Therapeutics Inc.
o Exhibit 95: Celldex Therapeutics Inc. - Overview
o Exhibit 96: Celldex Therapeutics Inc. - Product / Service
o Exhibit 97: Celldex Therapeutics Inc. - Key offerings
o 10.7 Eli Lilly and Co.
o Exhibit 98: Eli Lilly and Co. - Overview
o Exhibit 99: Eli Lilly and Co. - Product / Service
o Exhibit 100: Eli Lilly and Co. - Key offerings
o 10.8 F. Hoffmann La Roche Ltd.
o Exhibit 101: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 102: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 103: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 104: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 105: F. Hoffmann La Roche Ltd. - Segment focus
o 10.9 Hangzhou Adlai Nortye Biopharma Co. Ltd.
o Exhibit 106: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Overview
o Exhibit 107: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Product / Service
o Exhibit 108: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Key offerings
o 10.10 Merck KGaA
o Exhibit 109: Merck KGaA - Overview
o Exhibit 110: Merck KGaA - Business segments
o Exhibit 111: Merck KGaA - Key news
o Exhibit 112: Merck KGaA - Key offerings
o Exhibit 113: Merck KGaA - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 114: Pfizer Inc. - Overview
o Exhibit 115: Pfizer Inc. - Product / Service
o Exhibit 116: Pfizer Inc. - Key news
o Exhibit 117: Pfizer Inc. - Key offerings
o 10.12 Regeneron Pharmaceuticals Inc.
o Exhibit 118: Regeneron Pharmaceuticals Inc. - Overview
o Exhibit 119: Regeneron Pharmaceuticals Inc. - Product / Service
o Exhibit 120: Regeneron Pharmaceuticals Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 121: Inclusions checklist
o Exhibit 122: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 123: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 124: Research methodology
o Exhibit 125: Validation techniques employed for market sizing
o Exhibit 126: Information sources
o 11.5 List of abbreviations
o Exhibit 127: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Pharyngeal cancer - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Pharyngeal cancer - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Pharyngeal cancer - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Pharyngeal cancer - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Laryngeal cancer - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Laryngeal cancer - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Laryngeal cancer - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Laryngeal cancer - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Hungary - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Hungary - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Hungary - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Hungary - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Poland - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Poland - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Poland - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Poland - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Amgen Inc. - Overview
Exhibits86: Amgen Inc. - Product / Service
Exhibits87: Amgen Inc. - Key offerings
Exhibits88: AstraZeneca Plc - Overview
Exhibits89: AstraZeneca Plc - Product / Service
Exhibits90: AstraZeneca Plc - Key news
Exhibits91: AstraZeneca Plc - Key offerings
Exhibits92: Bristol Myers Squibb Co. - Overview
Exhibits93: Bristol Myers Squibb Co. - Product / Service
Exhibits94: Bristol Myers Squibb Co. - Key offerings
Exhibits95: Celldex Therapeutics Inc. - Overview
Exhibits96: Celldex Therapeutics Inc. - Product / Service
Exhibits97: Celldex Therapeutics Inc. - Key offerings
Exhibits98: Eli Lilly and Co. - Overview
Exhibits99: Eli Lilly and Co. - Product / Service
Exhibits100: Eli Lilly and Co. - Key offerings
Exhibits101: F. Hoffmann La Roche Ltd. - Overview
Exhibits102: F. Hoffmann La Roche Ltd. - Business segments
Exhibits103: F. Hoffmann La Roche Ltd. - Key news
Exhibits104: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits105: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits106: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Overview
Exhibits107: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Product / Service
Exhibits108: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Key offerings
Exhibits109: Merck KGaA - Overview
Exhibits110: Merck KGaA - Business segments
Exhibits111: Merck KGaA - Key news
Exhibits112: Merck KGaA - Key offerings
Exhibits113: Merck KGaA - Segment focus
Exhibits114: Pfizer Inc. - Overview
Exhibits115: Pfizer Inc. - Product / Service
Exhibits116: Pfizer Inc. - Key news
Exhibits117: Pfizer Inc. - Key offerings
Exhibits118: Regeneron Pharmaceuticals Inc. - Overview
Exhibits119: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits120: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits121: Inclusions checklist
Exhibits122: Exclusions checklist
Exhibits123: Currency conversion rates for US$
Exhibits124: Research methodology
Exhibits125: Validation techniques employed for market sizing
Exhibits126: Information sources
Exhibits127: List of abbreviations